Therapeutic Advances in Local-Regional Therapy for Stage III Non-Small-Cell Lung Cancer: Evolving Role of Dose-Escalated Conformal (3-Dimensional) Radiation Therapy
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference41 articles.
1. Cancer Facts and Figures 2006;American Cancer Society,2006
2. Current treatment of unresectable lung cancer;Jett;Mayo Clin Proc,1993
3. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003;Pfister;J Clin Oncol,2004
4. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group;Perez;Cancer,1987
5. Curran W, Scott C, Langer C, et al. Phase III comparisons of sequential vs concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer (NSCLC). Report of Radiation Therapy Oncology Group (RTOG) 9410. Program and abstracts of the 9th World Conference on Lung Cancer; September 11-15, 2000; Tokyo, Japan (Abstract #303).
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Purification and characterization of pleuroferin, a novel protein with in vitro anti-non-small cell lung cancer activity from the mushroom Pleurotus ferulae lanzi;Process Biochemistry;2022-11
2. Predicting personalised and progressive adaptive dose escalation to gross tumour volume using knowledge-based planning models for inoperable advanced-stage non-small cell lung cancer patients treated with volumetric modulated arc therapy;Biomedical Physics & Engineering Express;2022-03-04
3. GLP2-GLP2R signal affects the viability and EGFR-TKIs sensitivity of PC9 and HCC827 cells;BMC Pulmonary Medicine;2022-01-13
4. A treatment planning study comparison between supine and prone position for different lung tumour locations using CyberKnife TPS;Journal of Radiotherapy in Practice;2021-05-17
5. Targeting lung cancer using advanced drug delivery systems;Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems;2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3